383 related articles for article (PubMed ID: 23629720)
1. Dormancy is not necessary or sufficient for bacterial persistence.
Orman MA; Brynildsen MP
Antimicrob Agents Chemother; 2013 Jul; 57(7):3230-9. PubMed ID: 23629720
[TBL] [Abstract][Full Text] [Related]
2. Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.
Völzing KG; Brynildsen MP
mBio; 2015 Sep; 6(5):e00731-15. PubMed ID: 26330511
[TBL] [Abstract][Full Text] [Related]
3. Analyzing Persister Physiology with Fluorescence-Activated Cell Sorting.
Orman MA; Henry TC; DeCoste CJ; Brynildsen MP
Methods Mol Biol; 2016; 1333():83-100. PubMed ID: 26468102
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.
Hofsteenge N; van Nimwegen E; Silander OK
BMC Microbiol; 2013 Feb; 13():25. PubMed ID: 23379956
[TBL] [Abstract][Full Text] [Related]
5. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
[TBL] [Abstract][Full Text] [Related]
6. The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy.
Jõers A; Kaldalu N; Tenson T
J Bacteriol; 2010 Jul; 192(13):3379-84. PubMed ID: 20435730
[TBL] [Abstract][Full Text] [Related]
7. Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli.
Xu Y; Cui P; Zhang Y; Zhang W
Discov Med; 2020; 29(157):103-112. PubMed ID: 33002406
[TBL] [Abstract][Full Text] [Related]
8. Flow-cytometry analysis reveals persister resuscitation characteristics.
Mohiuddin SG; Kavousi P; Orman MA
BMC Microbiol; 2020 Jul; 20(1):202. PubMed ID: 32640993
[TBL] [Abstract][Full Text] [Related]
9. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
[TBL] [Abstract][Full Text] [Related]
10. The Dynamic Transition of Persistence toward the Viable but Nonculturable State during Stationary Phase Is Driven by Protein Aggregation.
Dewachter L; Bollen C; Wilmaerts D; Louwagie E; Herpels P; Matthay P; Khodaparast L; Khodaparast L; Rousseau F; Schymkowitz J; Michiels J
mBio; 2021 Aug; 12(4):e0070321. PubMed ID: 34340538
[TBL] [Abstract][Full Text] [Related]
11. Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria.
Gefen O; Gabay C; Mumcuoglu M; Engel G; Balaban NQ
Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6145-9. PubMed ID: 18427112
[TBL] [Abstract][Full Text] [Related]
12. Specific Enrichment and Proteomics Analysis of Escherichia coli Persisters from Rifampin Pretreatment.
Sulaiman JE; Hao C; Lam H
J Proteome Res; 2018 Nov; 17(11):3984-3996. PubMed ID: 30336045
[TBL] [Abstract][Full Text] [Related]
13. Single cell observations show persister cells wake based on ribosome content.
Kim JS; Yamasaki R; Song S; Zhang W; Wood TK
Environ Microbiol; 2018 Jun; 20(6):2085-2098. PubMed ID: 29528544
[TBL] [Abstract][Full Text] [Related]
14. Development of Persister-FACSeq: a method to massively parallelize quantification of persister physiology and its heterogeneity.
Henry TC; Brynildsen MP
Sci Rep; 2016 May; 6():25100. PubMed ID: 27142337
[TBL] [Abstract][Full Text] [Related]
15. Cell division in Escherichia coli cultures monitored at single cell resolution.
Roostalu J; Jõers A; Luidalepp H; Kaldalu N; Tenson T
BMC Microbiol; 2008 Apr; 8():68. PubMed ID: 18430255
[TBL] [Abstract][Full Text] [Related]
16. Revealing the Metabolic Activity of Persisters in Mycobacteria by Single-Cell D
Ueno H; Kato Y; Tabata KV; Noji H
Anal Chem; 2019 Dec; 91(23):15171-15178. PubMed ID: 31687804
[TBL] [Abstract][Full Text] [Related]
17. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
Li Y; Zhang Y
Antimicrob Agents Chemother; 2007 Jun; 51(6):2092-9. PubMed ID: 17420206
[TBL] [Abstract][Full Text] [Related]
18. Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.
Goneau LW; Yeoh NS; MacDonald KW; Cadieux PA; Burton JP; Razvi H; Reid G
Antimicrob Agents Chemother; 2014; 58(4):2089-97. PubMed ID: 24449771
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells.
Pu Y; Zhao Z; Li Y; Zou J; Ma Q; Zhao Y; Ke Y; Zhu Y; Chen H; Baker MAB; Ge H; Sun Y; Xie XS; Bai F
Mol Cell; 2016 Apr; 62(2):284-294. PubMed ID: 27105118
[TBL] [Abstract][Full Text] [Related]
20. Methods for Enrichment of Bacterial Persister Populations for Phenotypic Screens and Genomic Studies.
Adikari S; Hong-Geller E; Micheva-Viteva S
Methods Mol Biol; 2021; 2357():71-82. PubMed ID: 34590252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
